Copyright
©The Author(s) 2017.
World J Crit Care Med. Feb 4, 2017; 6(1): 65-73
Published online Feb 4, 2017. doi: 10.5492/wjccm.v6.i1.65
Published online Feb 4, 2017. doi: 10.5492/wjccm.v6.i1.65
Variable | Univariate | P value | Multivariate | P value | |
NO-H (n = 42) | No NO-H (n = 17) | Adjusted OR (95%CI) | |||
Bolus hydrocortisone, n (%) | 19 (45.2) | 13 (76.5) | 0.04 | 3.2 (0.5-26.5) | 0.99 |
Hydrocortisone taper, n (%) | 20 (64.5) | 3 (27.3) | 0.03 | 5.3 (1.8-34.5) | 0.04 |
Diabetes, n (%) | 11 (26.2) | 1 (5.9) | 0.08 | 6.2 (0.4-79.0) | 0.95 |
- Citation: Ibarra-Estrada MA, Chávez-Peña Q, Reynoso-Estrella CI, Rios-Zermeño J, Aguilera-González PE, García-Soto MA, Aguirre-Avalos G. Timing, method and discontinuation of hydrocortisone administration for septic shock patients. World J Crit Care Med 2017; 6(1): 65-73
- URL: https://www.wjgnet.com/2220-3141/full/v6/i1/65.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v6.i1.65